RAC 0.60% $1.69 race oncology ltd

Ann: Expanded Heart Protection Discovery for Zantrene, page-246

  1. 11,249 Posts.
    lightbulb Created with Sketch. 29637
    This AMGEN deal with Tenebio in July is interesting - a bit of a hybrid between a buyout and a partnership.

    This could be a potential transaction model for RACE where a single indication was sold rather than partnered.
    • The upfront cash could be partially distributed to shareholders via a capital return
    • Contingent milestones could provide additional upside and distributed to shareholders later
    • Rinse-repeat for other formulations
    https://www.amgen.com/newsroom/pres...ash-with-future-contingent-milestone-payments

    Screen Shot 2021-12-14 at 6.04.44 am.png

    and

    Screen Shot 2021-12-14 at 6.11.22 am.png
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.69
Change
0.010(0.60%)
Mkt cap ! $287.1M
Open High Low Value Volume
$1.69 $1.70 $1.65 $89.01K 53.2K

Buyers (Bids)

No. Vol. Price($)
1 2342 $1.69
 

Sellers (Offers)

Price($) Vol. No.
$1.70 5 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.